.cls-100{fill:#72c596;}.cls-200{fill:#8e9094;}.cls-300{fill:#231f20;}logo-medpace Real World Evidence (RWE) and Late Phase Research Bridging the gap from development to commercialization. Medpace uses our global operational reach and full service capabilities to help you achieve your scientific and commercial objectives. A highly qualified team of executives and specialists leads our Real World Evidence (RWE) and Late Phase Research efforts with years of clinical, observational, and economic research experience. Plan Early for Late Phase As the market access landscape continues to evolve, the timing of RWE and Late Phase Research is becoming increasingly important. Drawing upon our experience and expertise, Medpace can help you determine the best timing for initiating analyses earlier in the product development cycle and planning for later phase and post-marketing analyses. Whether it be earlier or later in the development cycle, Medpace can generate relevant evidence through the design and execution of prospective and retrospective observational studies including registries, safety studies, and expanded access programs. In addition, Medpace also has the capability to conduct standalone or piggyback economic analyses, such as cost-minimization and cost-effectiveness analyses, budget impact modeling, and evaluation of health-related quality of life (QOL) and other patient-reported outcomes (PROs). RWE and Late Phase Capabilities Expertise, resources and infrastructure to conduct earlier phase trials while designing and implementing plans for RWE and late phase research in support of your product Develop post-approval strategies that are well-integrated with early-stage clinical development plans Medical, regulatory, clinical, and RWE and late phase experts are deeply embedded in your studies to provide strategic and operational leadership Breadth of resources to conduct global research yet an agile culture that enables rapid adaptability as study requirements shift Targeted site selection reflecting real world drug and medical device use Dedicated submissions team to accelerate startup Global and localized regulatory leadership from early phase through late phase Medpace conducts both interventional and non-interventional RWE and Late Phase studies: Late phase randomized clinical trials (IIIb and IV) Observational epidemiologic studies Registries Post-authorization safety studies Expanded access programs Health economics and outcomes research Competitive marketing claims studies Telling the Value Story Click to Enlarge Click to Enlarge OUR LOCATIONS CAREERS LABS CAPABILITIES TECHNOLOGY RESOURCES INVESTORS INVESTIGATORS STUDY VOLUNTEERS BLOG ABOUT Mission Ethics and Compliance Global Reach Leadership Locations Careers SOLUTIONS Early Phase Clinical Research Phase II-III Clinical Research RWE - Late Phase Clinical Research Medical Device and Diagnostics THERAPEUTIC SPECIALITIES Autoimmune Diseases Cardiovascular Endocrine and Metabolic Hematology and Oncology Infectious Diseases and Vaccines NAFLD/NASH Nephrology Neuroscience Pediatrics Rare Disease and Orphan Indications Cellular & Gene Therapy CONTACT Medpace, Inc. 5375 Medpace Way Cincinnati, Ohio 45227 USA Toll-free: +1.800.730.5779 Tel: +1.513.579.9911 Fax: +1.513.579.0444  © 2021 Medpace, All Rights Reserved | Privacy Policy | UK Modern Slavery Act | Terms of Use | Sitemap Important Cookie Information – This message will only appear once. Medpace websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy. I AGREE